Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)-Reference-Cited by-同舟云学术

Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)

Published:2018-08 Issue: Volume:156 Page:55-63
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bauer Lisa,Ferla Salvatore^ORCID,Head Sarah A.,Bhat Shridhar,Pasunooti Kalyan K.,Shi Wei Q.^ORCID,Albulescu Lucian,Liu Jun O.,Brancale Andrea^ORCID,van Kuppeveld Frank J.M.,Strating Jeroen R.P.M.^ORCID

Funder

Netherlands Organisation for Scientific Research

European Union

PhRMA Foundation

US National Cancer Institute

JOL

ICTR

Life Science Research Network Wales

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference38 articles.

1. Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer;Aftab;Canc. Res.,2011

2. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP;Albulescu;Antivir. Res.,2015

3. Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer;Antonarakis;Oncol.,2013

4. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds;Arita;J. Virol.,2013

5. Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer;Bassetto;Eur. J. Med. Chem.,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid‐19;Reviews in Medical Virology;2023-12-29

2. Fabrication and optimization of itraconazole-loaded zein-based nanoparticles in coated capsules as a promising colon-targeting approach pursuing opportunistic fungal infections;Drug Delivery and Translational Research;2023-06-03

3. Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments;The Journal of Infectious Diseases;2023-03-09

4. Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances;Pharmaceuticals;2023-01-29

5. Combating coxsackievirus B infections;Reviews in Medical Virology;2022-11-12